-
COST-EFFECTIVENESS OF TRANSCUTANEOUS CARBON DIOXIDE THERAPY VERSUS STANDARD OF CARE FOR DIABETIC FOOT ULCER HEALING AND AMPUTATION PREVENTION: A MODEL-BASED ANALYSIS FROM THE SWISS PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
A COST-UTILITY ANALYSIS OF SUBCUTANEOUS VERSUS ORAL METHOTREXATE FOR TREATMENT OF RHEUMATOID ARTHRITIS IN PORTUGAL
Aug 11, 2026, 17:16 PM -
CLINICAL IDENTIFICATION AND MANAGEMENT PATTERNS IN ALCOHOL USE DISORDER (AUD): EVIDENCE FROM NORSTELLALINQ STRUCTURED AND HUMAN-IN-THE-LOOP LARGE LANGUAGE MODEL (LLM) EXTRACTED CLINICAL DATA
Aug 11, 2026, 17:16 PM -
INTEGRATING MULTILEVEL NETWORK META-REGRESSION (ML-NMR) INTO EXCEL COST-EFFECTIVENESS MODELS USING CONDITIONAL M-SPLINE SURVIVAL CURVES
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF PSORIASIS WITH CONCURRENT OR SUBSEQUENT PSORIATIC ARTHRITIS: A RETROSPECTIVE OBSERVATIONAL STUDY IN GERMANY
Aug 11, 2026, 17:16 PM -
BRINGING TACROLIMUS MONITORING HOME: A DISCRETE CHOICE EXPERIMENT OF PATIENT PREFERENCES IN ORGAN TRANSPLANTATION
Aug 11, 2026, 17:16 PM -
ASSESSING THE ENVIRONMENTAL IMPACT OF HEALTH INTERVENTIONS IN HTA: A YEAR OF PROGRESS
Aug 11, 2026, 17:16 PM -
DETERMINATION OF MEANINGFUL WITHIN-PATIENT CHANGE THRESHOLDS (MWPC) FOR THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GASTRIC (FACT-GA) FROM STAR-221 TRIAL
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF DENGUE VACCINATION IN BANGLADESH
Aug 11, 2026, 17:16 PM -
ARE WE READI FOR DISEASE-SPECIFIC REFERENCE CASE EXTENSIONS? LESSONS FROM NICE'S OBESITY FRAMEWORK
Aug 11, 2026, 17:16 PM -
ECONOMIC OPTIMIZATION OF POLYMYXIN B EXPOSURE TARGETS USING AN INTEGRATED PHARMACOMETRIC-PHARMACOECONOMIC SIMULATION FRAMEWORK
Aug 11, 2026, 17:16 PM -
SOCIOECONOMIC DISPARITIES ACROSS THE NON-SMALL CELL LUNG CANCER PRECISION ONCOLOGY PATHWAY: A SCOPING REVIEW AND EVIDENCE GAP MAP
Aug 11, 2026, 17:16 PM -
ECONOMIC IMPACT OF CDST USE IN CROHN'S DISEASE: A FRENCH BUDGET IMPACT MODEL
Aug 11, 2026, 17:16 PM -
IDENTIFYING RESPIRATORY VACCINE ATTRIBUTES DRIVING PATIENT PREFERENCE: AN AI-SUPPORTED TARGETED LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
OPERATIONALIZING EUROPEAN UNION (EU) JOINT CLINICAL ASSESSMENT GUIDANCE (JCA) FOR INDIRECT TREATMENT COMPARISONS (ITCS): DEVELOPMENT AND APPLICATION OF A TRANSPARENCY FRAMEWORKASSESSMENTS
Aug 11, 2026, 17:16 PM -
ALTERNATIVE ACCESS MODELS FOR ANTI-OBESITY MEDICINES IN JAPAN UNDER REIMBURSEMENT CONSTRAINTS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS AND COST-UTILITY OF HIGH-DOSE INACTIVATED INFLUENZA VACCINE VERSUS STANDARD-DOSE INACTIVATED INFLUENZA VACCINE IN THE OLDER ADULTS AGED =65 YEARS IN POLAND
Aug 11, 2026, 17:16 PM -
THE INCIDENCE, MORTALITY, AND SURVIVAL OF MALIGNANT GASTRIC CANCER IN THE UNITED STATES: A SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) 2000-2023 DATABASE ANALYSIS
Aug 11, 2026, 17:16 PM -
ECONOMIC VALUES OF POLICY INTERVENTIONS TO REDUCE ANTIMICROBIAL RESISTANCE USE: A SCOPING REVIEW OF MODEL-BASED ECONOMIC EVALUATION STUDIES
Aug 11, 2026, 17:16 PM -
COMPARATIVE CHANGE IN HBA1C AND WEIGHT OUTCOMES BETWEEN OBESE AND NON-OBESE ADULTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH SGLT-2 INHIBITORS OR GLP-1 RECEPTOR AGONISTS
Aug 11, 2026, 17:16 PM
